Recursion OS
Approach
Impact
Pipeline
Partners
About
Team
Our Story
Our Values
News & Views
Press
Careers
Open Positions
About SLC
COVID-19 Response
Recursion OS
Approach
Impact
Pipeline
Partners
About
Team
Our Story
Our Values
News & Views
Press
Careers
Open Positions
About SLC
COVID-19 Response
Blogs and Publications
Sending the Ladder Down While Still Climbing
August 11, 2020
Chris Gibson, PhD
The Bio-ML Revolution: Who Will Be Drug Discovery’s Next Big Player?
February 7, 2020
Lina Nilsson
Inclusion: Let's Keep Learning Together
January 28, 2020
Heather Kirkby
Presidential Reflections… Before Another Big Year
January 9, 2020
Tina Larson
How Recursion Built a High Throughput Screening Lab Capable of Producing Four Petabytes of Biological Data
December 12, 2019
Ben Miller
Why Tech and Biotech VCs Talk Past Each Other
November 7, 2019
Chris Gibson
Last Week was Big for AI and Pharma
October 7, 2019
Chris Gibson
Building a Start-up Ecosystem for Utah Biotech Entrepreneurs
February 28, 2019
Tina Larson & Christopher Gibson
Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2
January 4, 2019
Ron Alfa
Empowering host factors to eradicate malaria
May 29, 2018
Yolanda Chong
Cell Painting, A high-content image-based assay for morphological profiling using multiplexed fluorescent dyes
September 28, 2017
Christopher C Gibson
Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation
September 28, 2017
Chris Gibson
Deep Learning and Biology: We've only just begun
August 22, 2017
Mason Victors
Batch- vs Stream-Processing: Distributed Computing for Biology
August 10, 2017
A.J. Williams
Calculating the incalculable
July 22, 2017
Chris Gibson
AI-Enabled Phenotrpic Screens Reveal Clinically Relevant Drugs
Recursion Pharmaceuticals
Welcoming our new Chief Scientific Officer, Dr. Sharath Hegde
Chris Gibson
.jpeg)
.jpeg)
